# Puma Biotechnology, Inc.: Form 8-K, filed Aug 18, 2023

- Company: [Puma Biotechnology, Inc.](/companies/pbyi.md) (CIK 1401667)
- Form: 8-K
- Filed: 2023-08-18
- Accepted by EDGAR: Aug 18, 2023, 20:17 ET
- Period: 2023-08-17
- Accession: 0001437749-23-024168
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1401667/000143774923024168/pbyi20230817_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401667/000143774923024168/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401667/000143774923024168/pbyi20230817_8k.htm

Filed Aug 18, 2023.
Source: SEC EDGAR, the filing index for accession 0001437749-23-024168. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.